CNTA
Centessa Pharmaceuticals PLC ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.15B
P/E Ratio
—
EPS
$-1.78
Beta
1.12
52W High
$40.26
52W Low
$12.05
50-Day MA
$39.64
200-Day MA
$28.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Centessa Pharmaceuticals PLC ADR
Centessa Pharmaceuticals Limited, a pharmaceutical company, develops and delivers drugs that change and improve the lives of patients. The company is headquartered in Cambridge, the United Kingdom.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-256.34M |
| Operating Margin | 0.00% |
| Return on Equity | -57.40% |
| Return on Assets | -27.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.15 |
| Price-to-Book | 12.62 |
| Price-to-Sales (TTM) | 409.21 |
| EV/Revenue | 397.25 |
| EV/EBITDA | 1.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $154.73M |
| Float | $92.48M |
| % Insiders | 0.52% |
| % Institutions | 96.98% |
Historical Volatility
HV 10-Day
3.59%
HV 20-Day
2.80%
HV 30-Day
2.76%
HV 60-Day
78.66%
HV Rank
5.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($44.17 target)
1
Strong Buy3
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026